Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKIN ELEMENTS LIMITED Director's Dealing 2020

Nov 18, 2020

65803_rns_2020-11-18_aadada6c-963e-471b-9b62-2e4d8d885199.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

19 November 2020

Australian Securities Exchange Level 40, Central Park 152-158 St Georges Tce Perth WA 6000

Dear Sir/Madam

APPENDIX 3Y LODGEMENT

Please find enclosed an Appendix 3Y – Change of Director’s Interest Notice for Mr Peter Malone of Skin Elements Limited (ASX: SKN) (Skin Elements, the Company) in respect of the expiry of 2,000,000 performance rights at 30 June 2020.

During the periodic review of our records, it became apparent that the Company did not previously disclose the expiry of the 2,000,000 performance rights at 30 June 2020, initially granted 30 November 2017, for Mr Malone in an Appendix 3Y. Accordingly, this change to the director’s holding has now been included in the enclosed appendix.

The Company and its Directors are aware of the obligation to comply with ASX Listing Rules, in this case specifically the disclosure obligations under Listing Rule 3.19A. The Company has a Corporate Governance Policy in place that deals directly with Continuous Disclosure, and the Directors have been reminded of their obligations under this Policy.

The Company notes that the matter of expiry was brought to the attention of the Company Secretary at the time however the filing of these records was not resolved. The Company has taken this opportunity to review its current arrangements regarding notification of interest changes to ensure that they are adequate, and does not consider any further steps necessary to ensure compliance with Listing Rule 3.19B.

Yours faithfully

==> picture [57 x 35] intentionally omitted <==

Ms Kate Sainty Joint Company Secretary

==> picture [544 x 12] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Skin Elements Limited
ABN 90 608 047 794

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Malone
Date of last notice 26 March 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. to the relevant Sovereign Empire Pty Ltd – Mr Masole director of this company
Mr Malone is a beneficiary
Date of change 30 June 2020
No. of securities held prior to change 23,638,490 ordinary fully paid shares11,397,128 listed options ($0.10, 31/12/20)2,814,106 unlisted options ($0.03, 31/12/20)29,000,000 performance rights
,, ornary uy pa sa11,397,128 listed options ($0.10, 32,814,106 unlisted options ($0.03,29,000,000 performance rights
Class Performance Rights (granted 30
Number acquired Nil
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Legal/73720794_2

Appendix 3Y Change of Director’s Interest Notice

Number disposed 2,000,000 performance rights
Value/Consideration n/a
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change 23,638,490 ordinary fully paid shares
11,397,128 listed options ($0.10, 31/12/20)
2,814,106 unlisted options ($0.03, 31/12/20)
27,000,000 performance rights
Nature of change Expiry of performance rights
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a
Nature of interest n/a
Name of registered holder n/a
(if issued securities)
Date of change n/a
No. and class of securities to which n/a
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired n/a
Interest disposed n/a
Value/Consideration n/a
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change n/a

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above No traded during a[+] closed period where prior written clearance was required?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade toproceed during this period? n/a
If prior written clearance was provided, on what date was thisprovided? n/a
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Legal/73720794_2